• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Israel News

#Israel: Israel in social media

  • About
  • Support Us
  • Tech Jobs
  • Contact

Israel Approves CytoSorb Registration, CytoSorbents Announces Gad Medical as Distributor

March 25, 2019 By admin

CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces that the Medical Device Division of the State of Israel Ministry of Health medical device regulation unit (AMAR), has granted registration of CytoSorb in Israel, clearing the way to begin selling the device in the country.

Mr. Vincent Capponi, Chief Operating Officer of CytoSorbents stated, “We are pleased to bring CytoSorb to Israel, a country well-known for its excellent medical practices, especially in critical care and cardiac surgery, and the development and adoption of new medical technologies.”

CytoSorbents also announced its new Israeli distributor, Gad Medical, who will have exclusive rights to sell CytoSorb for all applications in Israel. Mr. David Frances, CEO of Gad Medical stated, “Now that CytoSorb is registered in Israel, we are excited to work with CytoSorbents on the launch of CytoSorb in the country. Gad Medical specializes in selling cardiovascular medical devices as the exclusive distributor for Terumo Cardiovascular in Israel, and distributes many new and innovative medical devices in other medical fields. Because of this, we believe we are ideally suited to promote and sell CytoSorb in the country.”

Israel has a population of approximately 9 million people, and has one of the largest healthcare systems in the Middle East, spending 7.6% of its gross domestic product (GDP) on healthcare each year. Its citizens are served by 44 general hospitals and the most physicians per capita in the world. All citizens are covered by universal healthcare insurance, administered by one of four national healthcare institutes, and often supplement this universal coverage with private insurance. In 2015, the Israeli Ministry of Health estimated that sepsis was the 6th leading cause of death in the country, costing approximately $1.8 billion per year to treat. According to the Israel Heart Society, heart disease is the second leading cause of death in the country. More than 10,000 cardiothoracic surgeries are performed each year at 13 medical centers.

About Gad Medical

Founded in 2013, Gad Medical is an importing and marketing company based out of Israel specializing in the health and medical fields, focusing on innovative and cutting-edge technology devices and equipment to rapidly become market leaders. The company has an annual growth rate exceeding 50% a year, marketing a variety of products in the fields of cardiovascular, Interventional cardiology and radiology, oncology, neurology and neurosurgery, orthopedics, and pain treatment.

About CytoSorbents Corporation (NASDAQ: CTSO)

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 55 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents is conducting its pivotal REFRESH 2-AKI trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 56,000 human treatments to date.

CytoSorbents’ purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $26 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM), and others. The Company has numerous products under development based upon this unique blood purification technology protected by many issued U.S. and international patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company’s websites at www.cytosorbents.com and www.cytosorb.com or follow us on Facebook and Twitter.

Filed Under: Featured Posts

Footer

Recent Posts

  • Evangelical Leaders Urge Trump to Reaffirm Israel’s Sovereignty over Judea and Samaria
  • Check Point and Wiz Roll Out Unified Cloud Security Solution Globally
  • Qatar in Gaza: The Fox Guarding the Henhouse
  • Ryanair Threats Fall Flat as Wizz Air Expands in Israel
  • Gustavo Petro Exposed: Colombia’s President Wages a Dangerous Campaign Against Israel
  • Microsoft vs. Israel’s Unit 8200: Trump Steps In
  • Cognyte Showcases AI-Driven Investigative Analytics at IACP 2025, October 18-21, Denver, Colorado
  • Microsoft’s Suspension of Services to Unit 8200: Risks, Openings, and the Geopolitical Shadow
  • A Swarm of the Sea: Jellyfish Blanket Israel’s Coastline from Ashkelon to Haifa
  • Haifa’s Real Estate: A Bubble on the Brink

Media Partners

  • Cybersecurity Market
  • Media Partners
Halo Security Enhances Platform with Custom Dashboards and Reports
Zenity Unveils Full Agenda for AI Agent Security Summit 2025 in San Francisco
CrowdStrike and Amazon’s Business Prime Put Enterprise-Grade Cybersecurity Within Reach of SMBs
Zania Secures $18 Million Series A to Accelerate Agentic AI for Security GRC
Cyberhill Unveils Wolverine: The AI-Powered Digital Twin for Cybersecurity Stacks
Axonius CTRL/ACT, October 22–23, 2025, Virtual
ThreatBook Launches Best-of-Breed Advanced Threat Intelligence Solution
IQM Raises $320 Million, Becomes Quantum Unicorn
Cybersecurity Providers Zero in on SMBs as Prime Targets
Commvault Unveils SHIFT 2025: Cyber Resilience in the Age of AI
Media Instances
App Coding
Briefly
VPNW
Market Research Media
Press Media Release
API Course
Studio Tel Aviv
Abbreviatory
Media Presser

Media Partners

  • Defense Market
  • Media Partners
Dutch Harbor Brands Launches Single-Step, Military-Inspired Tactical Line of Wipes
FARNBOROUGH International: Belgium’s Aerospace & Defence companies team up with UK Industry — Booth #1157
Motorola Solutions Acquires RapidDeploy to Transform Emergency Response Technology
Gaming Technology in the Defense Market: Training, Simulation, and Development
Lumen Technologies has won a $223 million contract from DISA
General Dynamics Electric Boat Wins $642 Million Submarine Support Contract
AeroVironment’s JUMP 20 VTOL UAS Surpasses Expectations in Maritime Operations
V2X Secures $103 Million Contract for U.S. Navy C-26 Aircraft Maintenance
Precision on the Modern Battlefield: U.S. Army Orders $13M in SMASH 2000L Fire Control Systems
CACI Secures $239 Million Task Order for U.S. Army Unified Network Modernization
MKTG Dev
Passerby
Game Tech Market
Opinion
Photo Studio
Pxef
Press Media Release
Transportational
Policymaker
Side Hustle Art

Copyright © 2015 IsraelNews.org

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT